FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market: GlobalData EP News Bureau Feb 24, 2026 GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 August 2026 PDUFA date, could introduce the first…
